Evidence map›Paper›PMID 30050065›Full record

ArticleCell death & disease2018

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.

Chiara Milanese, Silvia Cerri, Ayse Ulusoy, Simona V Gornati, Audrey Plat, Sylvia Gabriels, Fabio Blandini, Donato A Di Monte, Jan H Hoeijmakers, Pier G Mastroberardino

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pathological α-Synuclein Perturbs Nuclear Integrity.bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. NovelImmune network · 2025
    Article
  19. Article
  20. Aging, cellular senescence and Parkinson's disease.Journal of Parkinson's disease · 2025
    Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Chiara MilaneseDepartment of Molecular Genetics, Rotterdam, The Netherlands.
Silvia CerriLaboratory of Functional Neurochemistry, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Ayse UlusoyGerman Centre for Neurodegenerative Diseases (DZNE), 53175, Bonn, Germany.
Simona V GornatiDepartment of Neuroscience, Erasmus MC, 3015 GE, Rotterdam, The Netherlands.
Audrey PlatDepartment of Molecular Genetics, Rotterdam, The Netherlands.
Sylvia GabrielsDepartment of Molecular Genetics, Rotterdam, The Netherlands.
Fabio BlandiniLaboratory of Functional Neurochemistry, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Donato A Di MonteGerman Centre for Neurodegenerative Diseases (DZNE), 53175, Bonn, Germany.
Jan H HoeijmakersDepartment of Molecular Genetics, Rotterdam, The Netherlands.
Pier G MastroberardinoDepartment of Molecular Genetics, Rotterdam, The Netherlands. p.g.mastroberardino@erasmusmc.nl.
Rotterdam University of Applied Sciences · NLGerman Center for Neurodegenerative Diseases · DEErasmus University Rotterdam · NLUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The involvement of DNA damage and repair in aging processes is well established. Aging is an unequivocal risk factor for chronic neurodegenerative diseases, underscoring the relevance of investigations into the role that DNA alterations may have in the pathogenesis of these diseases. Consistently, even moderate impairment of DNA repair systems facilitates the onset of pathological features typical of PD that include derangement of the dopaminergic system, mitochondrial dysfunction, and alpha-synuclein stress. The latter establishes a connection between reduced DNA repair capacity and a cardinal feature of PD, alpha-synuclein pathology. It remains to be determined, however, whether alpha-synuclein stress activates in vivo the canonical signaling cascade associated with DNA damage, which is centered on the kinase ATM and substrates such as γH2Ax and 53BP1. Addressing these issues would shed light on age-related mechanisms impinging upon PD pathogenesis and neurodegeneration in particular. We analyzed two different synucleinopathy PD mouse models based either on intranigral delivery of AAV-expressing human alpha-synuclein, or intrastriatal injection of human alpha-synuclein pre-formed fibrils. In both cases, we detected a significant increase in γH2AX and 53BP1 foci, and in phospho-ATM immunoreactivity in dopaminergic neurons, which collectively indicate DNA damage and activation of the DNA damage response. Mechanistic experiments in cell cultures indicate that activation of the DNA damage response is caused, at least in part, by pro-oxidant species because it is prevented by exogenous or endogenous antioxidants, which also rescue mitochondrial anomalies caused by proteotoxic alpha-synuclein. These in vivo and in vitro findings reveal that the cellular stress mediated by alpha-synuclein-a pathological hallmark in PD-elicits DNA damage and activates the DNA damage response. The toxic cascade leading to DNA damage involves oxidant stress and mitochondrial dysfunction The data underscore the importance of DNA quality control for preservation of neuronal integrity and protection against neurodegenerative processes.

Indexed as

DNA Repairalpha-SynucleinAnimalsAtaxia Telangiectasia Mutated ProteinsCell Line, TumorDisease Models, AnimalDNA DamageDopaminergic NeuronsHistonesHumansMiceMice, Inbred C57BLMitochondriaParkinson DiseaseReactive Oxygen SpeciesSubstantia Nigraalpha-SynucleinAtaxia Telangiectasia Mutated Proteinsgamma-H2AX protein, mouseHistonesReactive Oxygen SpeciesTumor Suppressor p53-Binding Protein 1

Identifiers

PMID30050065
PMCPMC6062587
OpenAlexW2883768767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.